The appellants, Wagener and Cuttings, each underwent shoulder surgery during which a local anaesthetic, Regibloc Injection, manufactured by Pharmacare Ltd, was administered. Both allegedly suffered severe injuries, including tissue necrosis and paralysis, said to have been caused by the defective Regibloc. They sued Pharmacare in delict despite having no contractual relationship with it. Their main claim was based not on negligent manufacture, but on the allegation that Pharmacare, as manufacturer, was strictly liable for harm caused by a defective product. Pharmacare excepted to this claim on the basis that South African delict law requires proof of fault.